John T. Wilson
-
Vanderbilt researchers develop new approach to boost immunotherapy potency in cancer treatment
Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. Read MoreJun 17, 2025
-
New nanoparticles boost immune system in mice to fight skin, breast cancer
Vanderbilt researchers have developed a set of nanoparticles that stimulate the immune system in mice to fight cancer and may eventually do the same in humans. Read MoreJul 25, 2024
-
Nanoengineering may hold the key to developing more effective, safer treatments for a deadly childhood cancer
A grant from the National Institutes of Health will allow John T. Wilson to explore ways to use recently developed nanoparticles to stimulate immunity pathways in children, with the aim of making immunotherapy treatments for neuroblastoma more effective. Read MoreSep 16, 2022
-
Wilson awarded Komen breast cancer research grant
An engineering professor has received financial support from Susan G. Komen for breast cancer research. His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments. John T. Wilson, assistant professor of... Read MoreSep 25, 2019
-
Nanoparticle targets tumor-infiltrating immune cells, flips switch telling them to fight
A team of Vanderbilt University bioengineers announced a major breakthrough: designing a nanoscale particle that flips on cells' defenses to fight cancer. Read MoreJan 21, 2019